Overview on Origin, Transmission, Treatment and Clinical Researches of Sars-Cov-2

Elengoe, Asita; Selvam, Shalini

doi:10.30476/jhsss.2021.92409.1352

Document Type : Review Articles

Authors

Asita Elengoe ¹
Shalini Selvam ²

¹ Associate Professor, Department of Biotechnology, Faculty of Science, Lincoln University College, 47301 Petaling Jaya, Selangor, Malaysia

² Undergraduate Student, School of Biotechnology, Manipal International University (MIU), 71800, Putra Nilai, Negeri Sembilan, Malaysia

https://doi.org/10.30476/jhsss.2021.92409.1352

Abstract

Background: The year 2020 began with a new public health hazard. A novel coronavirus, acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was discovered in Wuhan, China on 12^th December 2019. In 2020, the World Health Organization (WHO) introduced the name of the disease as ‘COVID-19’.
Objective: The morphology, pathogenic mechanisms, causes, transmission, symptoms, diagnosis, therapeutic potential, clinical studies on COVID-19 infection, preventive measures, and mental health care were described in this study.
Methods: A literature search was conducted using electronic databases such as PubMed, Scopus, Elsevier, Frontiers, Medline, EMBASE, Web of Science, Science Direct, and Google Scholar. The search was broadly scoped, using key terms such as SARS-CoV-2, COVID-19, etc.
Results: The genomic characterization of SARS-CoV-2, drugs, and their potential mechanisms used in humans to inhibit the SARS-CoV-2 were tabulated. Moreover, twenty-five clinical researches carried out against COVID-19 infection were also tabulated in this study. Preventive measures such as chemical disinfectants and increasing test capacity were also discussed.
Conclusion: The current study provides a snapshot of the overview of the SARS-CoV-2 and COVID-19. The findings suggested the effective preventive measures to halt the spread of SARS-CoV-2 and develop a better vaccine. The information from this review study also aids in early preparations for future pandemic outbreaks.

Keywords

References

1. Shah AU, Safri SN, Thevadas R, Noordin NK, Abd Rahman A, Sekawi Z, Ideris A, Sultan MT. COVID-19 outbreak in Malaysia: Actions taken by the Malaysian government. International Journal of Infectious Diseases. 2020 Aug 1;97:108-16.

2. Pradhan D, Biswasroy P, Naik PK, Ghosh G, Rath G. A review of current interventions for COVID-19 prevention. Archives of Medical Research. 2020 Jul 1;51(5):363-74.

3. Singhal T. A review of coronavirus disease-2019 (COVID-19). The Indian Journal of Pediatrics. 2020 Apr;87(4):281-6.

4. World Health Organization. Coronavirus disease (COVID-2019) situation reports. 2020. Retrieved from: https://www.who.int/emergencies/diseases/novel- coronavirus- 2019/situation-reports (accessed on 16^th November 2020).

5. COVID CD, Team R, COVID C, Team R, COVID C, Team R, Bialek S, Boundy E, Bowen V, Chow N, Cohn A. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)-United States, February 12-March 16, 2020. Morbidity and mortality weekly report. 2020 Mar 27;69(12):343.

6. World Health Organization. Origin of SARS-CoV-2. 2020. Retrieved from https://apps.who.int/iris/handle/10665/332197 (accessed on 16^th November 2020).

7. Fong SJ, Dey N, Chaki J. An introduction to COVID-19. In Artificial intelligence for coronavirus outbreak 2021 (pp. 1-22). Springer, Singapore.

8. Aronson JK. Coronaviruses–a general introduction. Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford. 2020.

9. Kumar S, Nyodu R, Maurya VK, Saxena SK. Morphology, genome organization, replication, and pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus Disease 2019 (COVID-19). 2020:23.

10. Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, Xiang Z. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nature communications. 2020 Mar 27;11(1):1-2.

11. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID‐19) In StatPearls, Treasure Island (FL): StatPearls.

12. Khailany RA, Safdar M, Ozaslan M. Genomic characterization of a novel SARS- CoV-2. Gene reports. 2020 Jun 1;19:100682.

13. Vali M, Hassanzadeh J, Mirahmadizadeh A, Hoseini M, Dehghani S, Maleki Z, Méndez-Arriaga F, Ghaem H. Effect of meteorological factors and Air Quality Index on the COVID-19 epidemiological characteristics: an ecological study among 210 countries. Environmental Science and Pollution Research. 2021 May 22; 28(38):53116-53126.

14. COVID-19 Coronavirus pandemic. Worldometer. 2020. Retrieved from: https://www.worldometers.info/coronavirus/. (accessed on 16^th August 2021).

15. WHO. 2021. Retrieved from: https://www.who.int/emergencies/diseases/novel- coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19-schools (accessed on 6^th July 2021).

16. Chakraborty I, Maity P. COVID-19 outbreak: Migration, effects on society, global environment and prevention. Science of the Total Environment. 2020 Aug 1;728:138882.

17. Pak A, Adegboye OA, Adekunle AI, Rahman KM, McBryde ES, Eisen DP. Economic consequences of the COVID-19 outbreak: the need for epidemic preparedness. Frontiers in public health. 2020 May 29;8:241.

18. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research. 2020 Jul;24:91.

19. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status. Military Medical Research. 2020 Dec;7(1):1-0.

20. Elengoe A. COVID-19 Outbreak in Malaysia. Osong Public Health and Research Perspectives. 2020;11(3):93-100.

21. Yousefi M, Oskoei V, Jafari AJ, Farzadkia M, Firooz MH, Abdollahinejad B, Torkashvand J. Municipal solid waste management during COVID-19 pandemic: effects and repercussions. Environmental Science and Pollution Research. 2021 May 3;28:32200-9.

22. Henderson R, Edwards RJ, Mansouri K, Janowska K, Stalls V, Gobeil SM, Kopp M, Li D, Parks R, Hsu AL, Borgnia MJ. Controlling the SARS-CoV-2 spike glycoprotein conformation. Nature Structural & Molecular Biology. 2020 Oct;27(10):925-33.

23. Elengoe A, Selvam S, Selvarajah M, Manikam H, Vijaya R. Sequence analysis and structure prediction of Malaysia SARS-CoV-2 strain’s structural and accessory proteins. Biointerface Research in Applied Chemistry. 2022;12(1): 3259-3304.

24. Cevik M, Kuppalli K, Kindrachuk J, Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020 Oct 23;371.

25. Riva L, Yuan S, Yin X, Martin-Sancho L, Matsunaga N, Pache L, Burgstaller-Muehlbacher S, De Jesus PD, Teriete P, Hull MV, Chang MW. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature. 2020 Oct;586(7827):113-9.

26. Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. Journal of Preventive Medicine and Hygiene. 2020 Sep;61(3):E304.

27. Viner RM, Ward JL, Hudson LD, Ashe M, Patel SV, Hargreaves D, Whittaker E. Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents. Archives of Disease in Childhood. 2021 Aug 1;106(8):802-7.

28. Rossi GA, Sacco O, Mancino E, Cristiani L, Midulla F. Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases. Infection. 2020 Jul 31; 48(5): 665-9.

29. World Health Organization. Coronavirus disease (COVID-19): Vaccines. 2020. Retrieved from: https://www.who.int/news- room/q-a detail/coronavirus-disease-(covid-19)-vaccines. (accessed on 16^thNovember 2020).

30. Gallagher J. BBC News. COVID vaccine update: When will others be ready? 2020. Retrieved from: https://www.bbc.com/news/health- 51665497. (accessed on 16^th January 2021).

31. Trivedi A, Sharma S, Ashtey B. Investigational treatments for COVID-19. The Pharmaceutical Journal 2020; 304(7938):DOI:10.1211/PJ.2020.2020805.

32. Shaffer L. Nature medicine: 15 drugs being tested to treat COVID-19 and how they would work. 2020. Retrieved from https://www.nature.com/articles/d41591-020-00019-9#journal-info. (accessed on 16^th December 2020).

33. NIH: National Institute of Allergy and Infectious Diseases. 2020. Retrieved from COVID-19 Clinical Research: https://www.niaid.nih.gov/diseases- conditions/covid-19- clinical-research. (accessed on 16^th November 2020).

34. Zimmer C, Corum J, Wee S. The New York Times. Coronavirus Vaccine Tracker. 2020. Retrieved from:https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine tracker.html. (accessed on 16^th January 2021).

35. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020 May 12;323(18):1824-36.

36. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. Journal of Hospital Infection. 2020 Mar 1;104(3):246-51.

37. Al-Sayah MH. Chemical disinfectants of COVID-19: an overview. Journal of Water and Health. 2020 Oct 1;18(5):843-8.

38. Guner HR, Hasanoğlu İ, Aktaş F. COVID-19: Prevention and control measures in community. Turkish Journal of Medical Sciences. 2020 Apr 21;50(SI-1):571-7.

39. Al Dhaheri AS, Bataineh MA, Mohamad MN, Ajab A, Al Marzouqi A, Jarrar AH, Habib-Mourad C, Abu Jamous DO, Ali HI, Al Sabbah H, Hasan H. Impact of COVID-19 on mental health and quality of life: Is there any effect? A cross-sectional study of the MENA region. PloS One. 2021 Mar 25;16(3):e0249107.

40. Panchal N, Kamal R, Orgera K, Cox C, Garfield R, Hamel L, Chidambaram P. The implications of COVID-19 for mental health and substance use. Kaiser family foundation. 2020 Apr 21;21.

41. Dawel A, Shou Y, Smithson M, Cherbuin N, Banfield M, Calear AL, Farrer LM, Gray D, Gulliver A, Housen T, McCallum SM. The effect of COVID-19 on mental health and wellbeing in a representative sample of Australian adults. Frontiers in Psychiatry. 2020 Oct 6;11:1026.

Journal of Health Sciences & Surveillance System

Overview on Origin, Transmission, Treatment and Clinical Researches of Sars-Cov-2

References

References

Volume 10, Issue 1
January 2022
Pages 2-12

Overview on Origin, Transmission, Treatment and Clinical Researches of Sars-Cov-2

References

References

Volume 10, Issue 1January 2022Pages 2-12

Volume 10, Issue 1
January 2022
Pages 2-12